Covid-19 Vaccines 2020-11-17
2020-11-17
TAGS
Response quality
Questions & Answers
Q1
Direct Answer
▸
Context
The question arises from the need to understand the measures being taken by the Department to ensure adequate vaccine development and distribution.
What steps his Department is taking to support the development of covid-19 vaccines. The House will know that securing 5 million doses of the Moderna vaccine has been achieved, but further details on other measures are requested.
Yesterday, we secured 5 million doses of the Moderna vaccine, securing access to 355 million vaccine doses through agreements with seven separate vaccine developers. These vaccines will be available across the whole UK.
▸
Assessment & feedback
Response accuracy
Q2
Partial Answer
▸
Context
Concerns have been raised about the logistics of delivering vaccines to remote and rural regions, such as Cornwall.
What assessment has he done of the logistics necessary to deliver a vaccine to more rural areas, such as Cornwall? The deployment is being led by the NHS which reaches into all parts of the UK.
A significant amount of work has gone into how best to deploy the vaccine to rural areas. The deployment is led by the NHS and includes work focused on those who might find it most difficult to travel.
▸
Assessment & feedback
Specific logistical details are not provided, but an acknowledgment that the issue is being addressed.
Under Review
Response accuracy
Q3
Partial Answer
▸
Context
The question acknowledges the hard work of the Department and highlights the collaborative approach taken with the vaccine taskforce.
Does my right hon. Friend agree that securing doses of vaccines, as and when they become available, shows the power of all parts of the UK speaking with one voice and working together for the good of our entire Union?
I agree very strongly that vaccines should be available fairly and equally across all parts of the UK. The deployment will take place through the devolved NHS systems, with close collaboration between counterparts to ensure support for those clinically most vulnerable wherever they live.
▸
Assessment & feedback
Specific operational details on vaccine deployment in each part are not provided.
Working Closely
Response accuracy